Secondary outcomes by prior definitive treatment (tx) in patients (pts) with high-risk biochemically recurrent prostate cancer (hrBCR) treated with enzalutamide plus leuprolide (enza combo): EMBARK post hoc analysis

Journal article

Open access

Peer reviewed

S.J. Freedland, M. Gleave, U. De Giorgi, A.S. Rannikko, S. Sridharan, K. Brasso, H.H. Woo, A. Gómez Caamano, L.T. Nordquist, Y. Tang, …

European urology open science (Online), Vol.81, pp.S18-S19

11/2025

Files and links (1)

url

https://doi.org/10.1016/S2666-1683(25)01459-4View

Published (Version of record) Open

1 Record Views

Title: Secondary outcomes by prior definitive treatment (tx) in patients (pts) with high-risk biochemically recurrent prostate cancer (hrBCR) treated with enzalutamide plus leuprolide (enza combo): EMBARK post hoc analysis
Creators: S.J. Freedland
M. Gleave
U. De Giorgi
A.S. Rannikko
S. Sridharan
K. Brasso
H.H. Woo
A. Gómez Caamano
L.T. Nordquist
Y. Tang
R. Croitoru
M. Rosales
M. Kalac
O. Peraud
F. Wang
N.D. Shore
Publication Details: European urology open science (Online), Vol.81, pp.S18-S19
Identifiers: 991006262527102656
Academic Unit: Radiology
Language: English
Resource Type: Journal article